These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3293554)

  • 1. Childhood adrenoleukodystrophy. Failure of intensive immunosuppression to arrest neurologic progression.
    Naidu S; Bresnan MJ; Griffin D; O'Toole S; Moser HW
    Arch Neurol; 1988 Aug; 45(8):846-8. PubMed ID: 3293554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of repeated cyclophosphamide pulse therapy in childhood cerebral X-linked adrenoleukodystrophy.
    Horvath GA; Eichler F; Poskitt K; Stockler-Ipsiroglu S
    Neuropediatrics; 2012 Feb; 43(1):48-52. PubMed ID: 22430161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenoleukodystrophy. Failure of immunosuppression to prevent neurological progression.
    Stumpf DA; Hayward A; Haas R; Frost M; Schaumburg HH
    Arch Neurol; 1981 Jan; 38(1):48-9. PubMed ID: 7458724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenoleukodystrophy. Report of two cases with relapsing and remitting courses.
    Walsh PJ
    Arch Neurol; 1980 Jul; 37(7):448-50. PubMed ID: 6248004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Balo's concentric sclerosis with immunosuppressive drugs followed by multimodality evoked potentials and MRI.
    Louboutin JP; Elie B
    Muscle Nerve; 1995 Dec; 18(12):1478-80. PubMed ID: 7477074
    [No Abstract]   [Full Text] [Related]  

  • 6. MRI detects cerebral involvement in neurologically asymptomatic patients with adrenoleukodystrophy.
    Aubourg P; Sellier N; Chaussain JL; Kalifa G
    Neurology; 1989 Dec; 39(12):1619-21. PubMed ID: 2586779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenoleukodystrophy carrier state presenting as a chronic nonprogressive spinal cord disorder.
    Noetzel MJ; Landau WM; Moser HW
    Arch Neurol; 1987 May; 44(5):566-7. PubMed ID: 3579671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Electroencephalographic rhythms of alpha frequency in a comatose patient with adrenoleukodystrophy--the spectrum analysis of alpha wave in EEG and the electrophysiological studies of alpha-coma].
    Tanaka T; Tomita Y; Nishimura S
    No To Hattatsu; 1986; 18(6):490-7. PubMed ID: 3790349
    [No Abstract]   [Full Text] [Related]  

  • 9. [Case of adrenoleukodystrophy (ALD) with clinical features of olivopontocerebellar atrophy].
    Tsuchida H; Ohno T; Fukuhara N; Miyatake T
    Rinsho Shinkeigaku; 1983 Jun; 23(6):489-94. PubMed ID: 6652994
    [No Abstract]   [Full Text] [Related]  

  • 10. [An atypical case of adrenoleukodystrophy (ALD) with frontal lobe syndrome and slow progression].
    Arai Y; Matsuzaka T; Toyoda M; Sakuragawa N; Arima M
    No To Hattatsu; 1988 Jan; 20(1):33-7. PubMed ID: 3279980
    [No Abstract]   [Full Text] [Related]  

  • 11. Ophthalmologic manifestations of X-linked childhood adrenoleukodystrophy.
    Traboulsi EI; Maumenee IH
    Ophthalmology; 1987 Jan; 94(1):47-52. PubMed ID: 3561956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenomyeloneuropathy presenting as Addison's disease in childhood.
    Sadeghi-Nejad A; Senior B
    N Engl J Med; 1990 Jan; 322(1):13-6. PubMed ID: 2294415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenoleukodystrophy (ALD): clinical and CT features of a childhood variant.
    Marler JR; O'Neill BP; Forbes GS; Moser HW
    Neurology; 1983 Sep; 33(9):1203-5. PubMed ID: 6684256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetyl-L-cysteine improves outcome of advanced cerebral adrenoleukodystrophy.
    Tolar J; Orchard PJ; Bjoraker KJ; Ziegler RS; Shapiro EG; Charnas L
    Bone Marrow Transplant; 2007 Feb; 39(4):211-5. PubMed ID: 17290278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenoleukodystrophy and psychiatric disorder.
    Cohen-Cole S; Kitchin W
    Am J Psychiatry; 1985 Oct; 142(10):1224-5. PubMed ID: 4037139
    [No Abstract]   [Full Text] [Related]  

  • 16. Adrenoleukodystrophy. Report of a case with extremely slow progression of symptoms.
    Cavaletti G; Bogliun G; Tredici G
    Acta Neurol (Napoli); 1990 Apr; 12(2):109-14. PubMed ID: 2360475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary erucic acid therapy for X-linked adrenoleukodystrophy.
    Rizzo WB; Leshner RT; Odone A; Dammann AL; Craft DA; Jensen ME; Jennings SS; Davis S; Jaitly R; Sgro JA
    Neurology; 1989 Nov; 39(11):1415-22. PubMed ID: 2682348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenoleukodystrophy: abnormality of very long-chain fatty acids in erythrocyte membrane phospholipids.
    Antoku Y; Sakai T; Goto I; Iwashita H; Kuroiwa Y
    Neurology; 1984 Nov; 34(11):1499-1501. PubMed ID: 6493501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haploidentical bone marrow transplantation with post transplant cyclophosphamide for patients with X-linked adrenoleukodystrophy: a suitable choice in an urgent situation.
    Fernandes JF; Bonfim C; Kerbauy FR; Rodrigues M; Esteves I; Silva NH; Azambuja AP; Mantovani LF; Kutner JM; Loth G; Kuwahara CC; Bueno C; Kondo AT; Ribeiro AAF; Kok F; Hamerschlak N
    Bone Marrow Transplant; 2018 Apr; 53(4):392-399. PubMed ID: 29330393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes.
    Singh I; Moser AE; Moser HW; Kishimoto Y
    Pediatr Res; 1984 Mar; 18(3):286-90. PubMed ID: 6728562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.